Download - Module 205.3 en
![Page 1: Module 205.3 en](https://reader035.vdocuments.site/reader035/viewer/2022062400/58e49c421a28abf5428b5383/html5/thumbnails/1.jpg)
CHRONIC KIDNEY DISEASE
![Page 2: Module 205.3 en](https://reader035.vdocuments.site/reader035/viewer/2022062400/58e49c421a28abf5428b5383/html5/thumbnails/2.jpg)
Objectives
![Page 3: Module 205.3 en](https://reader035.vdocuments.site/reader035/viewer/2022062400/58e49c421a28abf5428b5383/html5/thumbnails/3.jpg)
Chronic kidney disease (CKD)
![Page 4: Module 205.3 en](https://reader035.vdocuments.site/reader035/viewer/2022062400/58e49c421a28abf5428b5383/html5/thumbnails/4.jpg)
Glomerular filtration rate (GFR)
![Page 5: Module 205.3 en](https://reader035.vdocuments.site/reader035/viewer/2022062400/58e49c421a28abf5428b5383/html5/thumbnails/5.jpg)
Risk factors
![Page 6: Module 205.3 en](https://reader035.vdocuments.site/reader035/viewer/2022062400/58e49c421a28abf5428b5383/html5/thumbnails/6.jpg)
Type 1 diabetes
![Page 7: Module 205.3 en](https://reader035.vdocuments.site/reader035/viewer/2022062400/58e49c421a28abf5428b5383/html5/thumbnails/7.jpg)
Natural history of chronic kidney disease
![Page 8: Module 205.3 en](https://reader035.vdocuments.site/reader035/viewer/2022062400/58e49c421a28abf5428b5383/html5/thumbnails/8.jpg)
Protein, microalbuminuria and macroalbuminuria
![Page 9: Module 205.3 en](https://reader035.vdocuments.site/reader035/viewer/2022062400/58e49c421a28abf5428b5383/html5/thumbnails/9.jpg)
Factors affecting albumin excretion
![Page 10: Module 205.3 en](https://reader035.vdocuments.site/reader035/viewer/2022062400/58e49c421a28abf5428b5383/html5/thumbnails/10.jpg)
Diabetic renal assessment
![Page 11: Module 205.3 en](https://reader035.vdocuments.site/reader035/viewer/2022062400/58e49c421a28abf5428b5383/html5/thumbnails/11.jpg)
Microalbuminuria
![Page 12: Module 205.3 en](https://reader035.vdocuments.site/reader035/viewer/2022062400/58e49c421a28abf5428b5383/html5/thumbnails/12.jpg)
Interventions: glycaemic control (1 of 2)
![Page 13: Module 205.3 en](https://reader035.vdocuments.site/reader035/viewer/2022062400/58e49c421a28abf5428b5383/html5/thumbnails/13.jpg)
Interventions: glycaemic control (2 of 2)
![Page 14: Module 205.3 en](https://reader035.vdocuments.site/reader035/viewer/2022062400/58e49c421a28abf5428b5383/html5/thumbnails/14.jpg)
Diabetic nephropathy
![Page 15: Module 205.3 en](https://reader035.vdocuments.site/reader035/viewer/2022062400/58e49c421a28abf5428b5383/html5/thumbnails/15.jpg)
Interventions: hypertension control
![Page 16: Module 205.3 en](https://reader035.vdocuments.site/reader035/viewer/2022062400/58e49c421a28abf5428b5383/html5/thumbnails/16.jpg)
Interventions: hypertension control
![Page 17: Module 205.3 en](https://reader035.vdocuments.site/reader035/viewer/2022062400/58e49c421a28abf5428b5383/html5/thumbnails/17.jpg)
Interventions: hypertension control
![Page 18: Module 205.3 en](https://reader035.vdocuments.site/reader035/viewer/2022062400/58e49c421a28abf5428b5383/html5/thumbnails/18.jpg)
Cautions with medications and CKD (1 of 2)
![Page 19: Module 205.3 en](https://reader035.vdocuments.site/reader035/viewer/2022062400/58e49c421a28abf5428b5383/html5/thumbnails/19.jpg)
Cautions with medications and CKD (2 of 2)
![Page 20: Module 205.3 en](https://reader035.vdocuments.site/reader035/viewer/2022062400/58e49c421a28abf5428b5383/html5/thumbnails/20.jpg)
Management of people with elevated creatinine
![Page 21: Module 205.3 en](https://reader035.vdocuments.site/reader035/viewer/2022062400/58e49c421a28abf5428b5383/html5/thumbnails/21.jpg)
CKD - Clinical features
![Page 22: Module 205.3 en](https://reader035.vdocuments.site/reader035/viewer/2022062400/58e49c421a28abf5428b5383/html5/thumbnails/22.jpg)
Nutritional needs
![Page 23: Module 205.3 en](https://reader035.vdocuments.site/reader035/viewer/2022062400/58e49c421a28abf5428b5383/html5/thumbnails/23.jpg)
Estimated glomerular filtration rate (eGFR) (1 of 2)
![Page 24: Module 205.3 en](https://reader035.vdocuments.site/reader035/viewer/2022062400/58e49c421a28abf5428b5383/html5/thumbnails/24.jpg)
Estimated glomerular filtration rate (eGFR) (2 of 2)
![Page 25: Module 205.3 en](https://reader035.vdocuments.site/reader035/viewer/2022062400/58e49c421a28abf5428b5383/html5/thumbnails/25.jpg)
Treatment of End Stage Renal Disease ESRD
![Page 26: Module 205.3 en](https://reader035.vdocuments.site/reader035/viewer/2022062400/58e49c421a28abf5428b5383/html5/thumbnails/26.jpg)
Special problems in peritoneal dialysis
![Page 27: Module 205.3 en](https://reader035.vdocuments.site/reader035/viewer/2022062400/58e49c421a28abf5428b5383/html5/thumbnails/27.jpg)
Special problems in hemodialysis
![Page 28: Module 205.3 en](https://reader035.vdocuments.site/reader035/viewer/2022062400/58e49c421a28abf5428b5383/html5/thumbnails/28.jpg)
Activity
![Page 29: Module 205.3 en](https://reader035.vdocuments.site/reader035/viewer/2022062400/58e49c421a28abf5428b5383/html5/thumbnails/29.jpg)
Summary
![Page 30: Module 205.3 en](https://reader035.vdocuments.site/reader035/viewer/2022062400/58e49c421a28abf5428b5383/html5/thumbnails/30.jpg)
References
![Page 31: Module 205.3 en](https://reader035.vdocuments.site/reader035/viewer/2022062400/58e49c421a28abf5428b5383/html5/thumbnails/31.jpg)
References